Diagnostic Value of a Chimeric TSH Receptor (Mc4)-Based Bioassay for Graves' Disease
Ji In Lee, Hye Won Jang, Soo Kyoung Kim, Joon Young Choi, Ji Young Kim, Kyu Yeon Hur, Jae Hyeon Kim, Yong-Ki Min, Jae Hoon Chung, Sun Wook Kim
Korean J Intern Med. 2011;26(2):179-186. Published online 2011 Jun 1 DOI: https://doi.org/10.3904/kjim.2011.26.2.179
Citations to this article as recorded by 
Interpretation of Thyroid Autoantibodies in Hyperthyroidism
Han-Sang Baek, Dong-Jun Lim
The Korean Journal of Medicine.2023; 98(3): 132. CrossRef
The prevalence of positive thyroid autoantibodies in patients with subacute thyroiditis: a systematic review and meta-analysis
Arman Shekarian, Mohammad Fakhrolmobasheri, Sadegh Mazaheri-Tehrani, Amirhossein Yousefian, Maryam Heidarpour
Endocrine.2023; 84(1): 29. CrossRef
Receptor modulators associated with the hypothalamus -pituitary-thyroid axis
Xianbin Cheng, Hong Zhang, Shanshan Guan, Qi Zhao, Yaming Shan
Frontiers in Pharmacology.2023;[Epub] CrossRef
Differential Diagnosis of Thyrotoxicosis by Machine Learning Models with Laboratory Findings
Jinyoung Kim, Han-Sang Baek, Jeonghoon Ha, Mee Kyoung Kim, Hyuk-Sang Kwon, Ki-Ho Song, Dong-Jun Lim, Ki-Hyun Baek
Diagnostics.2022; 12(6): 1468. CrossRef
The prognostic value of thyroid-stimulating immunoglobulin in the management of Graves’ disease
Yulin Zhou, Mengxi Zhou, Yicheng Qi, Weiqing Wang, Xinxin Chen, Shu Wang
Therapeutic Advances in Endocrinology and Metabolism.2021; 12: 204201882110449. CrossRef
Prospective Trial of Functional Thyrotropin Receptor Antibodies in Graves Disease
George J Kahaly, Tanja Diana, Michael Kanitz, Lara Frommer, Paul D Olivo
The Journal of Clinical Endocrinology & Metabolism.2020; 105(4): e1006. CrossRef
Usefulness of TSH receptor antibodies as biomarkers for Graves’ ophthalmopathy: a systematic review
S. Seo, M. Sánchez Robledo
Journal of Endocrinological Investigation.2018; 41(12): 1457. CrossRef
Evaluation of the first fully automated immunoassay method for the measurement of stimulating TSH receptor autoantibodies in Graves’ disease
Renato Tozzoli, Federica D’Aurizio, Danilo Villalta, Luca Giovanella
Clinical Chemistry and Laboratory Medicine (CCLM).2017; 55(1): 58. CrossRef
High cut-off value of a chimeric TSH receptor (Mc4)-based bioassay may improve prediction of relapse in Graves’ disease for 12 months
Sena Hwang, Dong Yeob Shin, Mi Kyung Song, Eun Jig Lee
Endocrine.2015; 48(1): 89. CrossRef
Clinical Relevance of Thyroid-Stimulating Autoantibodies in Pediatric Graves' Disease—A Multicenter Study
T. Diana, R. S. Brown, A. Bossowski, M. Segni, M. Niedziela, J. König, A. Bossowska, K. Ziora, A. Hale, J. Smith, S. Pitz, M. Kanitz, G. J. Kahaly
The Journal of Clinical Endocrinology & Metabolism.2014; 99(5): 1648. CrossRef